Cognition Therapeutics, Inc. ( CGTX) - Stock Earnings
CGTX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
CGTX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -3.3 million USD | — USD |
| 2026Q1 | -4.6 million USD | — USD |
| 2026Q2 | -3.9 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
CGTX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -25.8 million USD | — USD |
| 2024 | -34.0 million USD | — USD |
| 2025 | -23.5 million USD | — USD |
| 2026 Est. | — | — |
CGTX
Price: $0.73
52 week price:
Earnings Per Share: -0.17 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 239600
Market Capitalization: 84.0 million